Toshiba's AIDR 3D Receives FDA Clearance

Thanh Le | | Radiology Business | Business Intelligence
Toshiba America Medical Systems, Inc. has received FDA clearance of Adaptive Iterative Dose Reduction 3D (AIDR 3D), the company’s newest dose-reduction technology. AIDR 3D is Toshiba’s third generation iterative dose reconstruction software that reduces radiation dose compared to conventional scanning. The algorithm is designed to work in both the raw data and image data space, reducing noise while attempting to maintain image quality. AIDR 3D can also be seamlessly integrated with SUREExposureTM 3D, a software that calculates the minimum radiation exposure required for every exam. SUREExposure 3D adjusts the dose for each patient based on a preset, targeted level of image quality. Toshiba says it will offer the AIDR 3D software upgrade and related training, complimentary, to all existing Aquilion™ ONE, Aquilion Premium and Aquilion PRIME CT customers.View the press release for additional information.

Thanh Le

Related Content

Orano Med breaks ground on $265M thorium production site
Image-interpretation market scoreboard: Radiologists 72%, others 28%
Lantheus lands rights to budding radiopharmaceuticals for initial outlay of $35M
17 short-term strategies to address the national radiologist shortage
‘SR’ onboards another independent practice, its 1st in the Natural State
Analysis: Allied radiology professionals generate millions of dollars per year in indirect revenues alone

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.